Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth K Schorry

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 2, 2007
The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1David A Stevenson, David H Viskochil, Elizabeth K Schorry, et al.
Journal of Patient-Reported Outcomes|April 30, 2025
Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findingsNour Al Ghriwati, Kari Struemph, Staci Martin, et al.
Pediatric Neurology|March 30, 2023
Motor Function and Physiology in Youth With Neurofibromatosis Type 1Alexander C Doherty, David A Huddleston, Paul S Horn, et al.
Journal of Health Psychology|July 13, 2025
Qualitative aspects of pain in children and adults with neurofibromatosis type 1 and plexiform neurofibromas: Causes, consequences, and communicationMelissa Baker, Staci Martin, Nour Al Ghriwati, et al.
American Journal of Medical Genetics. Part A|March 27, 2013
Fractures in children with neurofibromatosis type 1 from two NF clinicsJaya K George-Abraham, Lisa J Martin, Heidi J Kalkwarf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Annals of Neurology|November 25, 2004
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndromeYang Tang, Mark B Schapiro, David N Franz, et al.
Journal of Pediatric Orthopedics|August 28, 2020
Are Some Randomized Clinical Trials Impossible?Jonathan J Rios, B Stephens Richards, David A Stevenson, et al.
Neurology|July 7, 2021
Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical TrialsPamela L Wolters, Ana-Maria Vranceanu, Heather L Thompson, et al.
Human Genetics|June 27, 2009
Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mappingAyman W El-Hattab, Teresa A Smolarek, Martha E Walker, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 2, 2007
The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1David A Stevenson, David H Viskochil, Elizabeth K Schorry, et al.
Journal of Patient-Reported Outcomes|April 30, 2025
Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findingsNour Al Ghriwati, Kari Struemph, Staci Martin, et al.
Pediatric Neurology|March 30, 2023
Motor Function and Physiology in Youth With Neurofibromatosis Type 1Alexander C Doherty, David A Huddleston, Paul S Horn, et al.
Journal of Health Psychology|July 13, 2025
Qualitative aspects of pain in children and adults with neurofibromatosis type 1 and plexiform neurofibromas: Causes, consequences, and communicationMelissa Baker, Staci Martin, Nour Al Ghriwati, et al.
American Journal of Medical Genetics. Part A|March 27, 2013
Fractures in children with neurofibromatosis type 1 from two NF clinicsJaya K George-Abraham, Lisa J Martin, Heidi J Kalkwarf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Annals of Neurology|November 25, 2004
Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndromeYang Tang, Mark B Schapiro, David N Franz, et al.
Journal of Pediatric Orthopedics|August 28, 2020
Are Some Randomized Clinical Trials Impossible?Jonathan J Rios, B Stephens Richards, David A Stevenson, et al.
Neurology|July 7, 2021
Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical TrialsPamela L Wolters, Ana-Maria Vranceanu, Heather L Thompson, et al.
Human Genetics|June 27, 2009
Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mappingAyman W El-Hattab, Teresa A Smolarek, Martha E Walker, et al.
Pageof 5